56例慢性阻塞性肺病并呼吸衰竭临床治疗分析

Clinical Analysis of 56 Cases of Chronic Obstructive Pulmonary Disease and Respiratory Failure

目的研究并探讨采用无创正压通气治疗慢性阻塞性肺病并呼吸衰竭患者的临床治疗效果。方法选取我院自2013年8月~2014年9月期间收治的56例慢性阻塞性肺病并呼吸衰竭患者作为研究对象,将所有患者随机分为实验组和对照组,每组患者28例,两组患者分别采用不同的治疗方法进行治疗。比较两组临床治疗效果情况。结果实验组患者的临床治疗效果高于对照组患者,实验组患者的平均通气时间以及住院时间低于对照组患者,实验组患者发生不良反应的患者数量也低于对照组患者,组间差异明显（P〈0.05）,具有统计学意义。结论采用无创正压通气法治疗慢性阻塞性肺病并呼吸衰竭的临床治疗效果较好,安全可靠。

Objective To study and evaluate the clinical therapeutic effect of noninvasive positive pressure ventilation in the treatment of chronic obstructive pulmonary disease patients with respiratory failure. Methods In our hospital from 56 cases of chronic obstructive pulmonary disease patients with respiratory failure treated during 2013 August to 2014 September as the research object, all patients were randomly divided into experimental group and control group, 28 cases in each group, Two groups of patients were treated with different treatment methods. Comparison between two groups of patients with clinical curative effect of patients. Results The clinical treatment effect of the experimental group were significantly higher than the control group, the average ventilation time and hospitalization time of the experimental group were significantly lower than the control group, the number of patients with adverse reactions of the patients in the experimental group were significantly lower than the control group, the differences between groups were statistically significant（P〈0.05）. Conclusion The clinical effect of noninvasive positive pressure ventilation in the treatment of chronic obstructive pulmonary disease and respiratory failure is good, safe and reliable.